• CDC News
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatology
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Clinical Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Orthopedics
  • Obesity Medicine
  • Rheumatology
  • Technology
  • Oncology
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Severe Asthma Research Recap: 8 Updates for Primary Care

Slideshow

Research summaries on GINA revisions, a steroid-reduction algorithm, factors that predict asthma exacerbation risk, and more.

Global Initiative for Asthma (GINA) treatment divided into tracks, greater precision in exacerbation risk prediction, an individualized algorithm to reduce steroids, and reasons why patients don't adhere to treatment—these are some of the more significant recent developments in severe asthma research.

Scroll through the slides below for concise summaries of the latest findings.


Related Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
© 2025 MJH Life Sciences

All rights reserved.